Controlled Release Drug Delivery Market Size

  • Report ID: 726
  • Published Date: Dec 23, 2024
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2025-2037

Controlled Release Drug Delivery Market size was valued at USD 59.83 billion in 2024 and is likely to cross USD 192.37 billion by 2037, expanding at more than 9.4% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of controlled release drug delivery is estimated at USD 64.61 billion.

The key factors driving the growth of this market include the low treatment cost, reduced drug toxicity along with the increased therapeutic efficacy. Moreover, these technologies provide various advantages over traditional delivery systems, such as, uniform drug level which stabilizes the medical condition, reduced dosage and less side effects, and is also a significant factor anticipated to fuel the growth of the controlled release drug delivery system market over the forecast period.



Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of controlled release drug delivery is estimated at USD 64.61 billion.

Controlled Release Drug Delivery Market size was valued at USD 59.83 billion in 2024 and is likely to cross USD 192.37 billion by 2037, expanding at more than 9.4% CAGR during the forecast period i.e., between 2025-2037.

North America industry is expected to account for largest revenue share by 2037, driven by prevailing diseases related to gastrointestinal disorders, advancement in the technological infrastructure of pharmaceutical industry, along with increasing activities of research & development.

The major players in the market are Pfizer Inc., Mayne Pharma, AstraZeneca Plc, Insulet Corporation, Becton Dickinson and Co, Bespak, West Pharmaceutical Services, Enable Injections Inc, Biogen Inc., and others.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos